EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

ORAL COMMUNICATION | Comparison of HAS-BLED and DOAC score for bleeding risk prediction in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: a real-world cohort study.

A. Trovati, S. Ballestri, M. Bergamini, F. Zanni, B. Cuneo, L. Orlandi, M. Pasquinelli, M. Capitelli

Italian Journal of Medicine · 22.05.2026 · 20 (s1)

DOI: 10.4081/itjm.2026.2579 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Italian Journal of Medicine, online erschienen am 22.05.2026. Verfasst von A. Trovati und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bleeding risk assessment is recommended in patients with atrial fibrillation (AF) receiving oral anticoagulant therapy. HAS-BLED is the most commonly used score, but it was developed in vitamin K antagonist–treated populations and shows limited predictive ability. As direct oral anticoagulants (DOACs) are now first-line therapy in non-valvular AF, a DOAC-specific bleeding risk score was proposed in 2023, called the “DOAC score." This study aimed to compare the predictive accuracy of the two scores. Materials and Methods. We conducted a retrospective observational study including patients with non-valvular AF treated with DOACs and followed at the Anticoagulation Center of Pavullo Hospital (AUSL Modena). HAS-BLED and DOAC scores were calculated. Predictive performance for major bleeding (MB) and for the combined endpoint of MB and clinically relevant non-major bleeding (CRNMB) was assessed using ROC curve analysis.

Results

The analysis included 228 patients (mean age 80.7 ± 8.6 years; 41.7% women). Major bleeding occurred in 16.2% of patients, while 25.0% experienced clinically significant bleeding. Both scores showed modest predictive ability for major bleeding (AUC 0.63 for the DOAC score and 0.59 for the HAS-BLED). The DOAC score demonstrated superior performance for both major bleeding and the combined endpoint of MB and CRNMB (AUC 0.66 vs 0.57; p = 0.02).

Conclusions

In a real-world cohort of patients with non-valvular AF treated with DOACs, the DOAC score outperformed HAS-BLED in predicting bleeding events, despite overall modest discrimination.

Zitieren

APA

Trovati, A., Ballestri, S., Bergamini, M., Zanni, F., Cuneo, B., Orlandi, L., Pasquinelli, M., & Capitelli, M. (2026). ORAL COMMUNICATION | Comparison of HAS-BLED and DOAC score for bleeding risk prediction in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: a real-world cohort study. Italian Journal of Medicine, 20(s1). https://doi.org/10.4081/itjm.2026.2579

Vancouver

Trovati A, Ballestri S, Bergamini M, Zanni F, Cuneo B, Orlandi L, et al. ORAL COMMUNICATION | Comparison of HAS-BLED and DOAC score for bleeding risk prediction in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: a real-world cohort study. Italian Journal of Medicine. 2026;20(s1). doi:10.4081/itjm.2026.2579

BibTeX
@article{Trovati2026,
  author = {Trovati, A. and Ballestri, S. and Bergamini, M. and Zanni, F. and Cuneo, B. and Orlandi, L. and Pasquinelli, M. and Capitelli, M.},
  title = {ORAL COMMUNICATION | Comparison of HAS-BLED and DOAC score for bleeding risk prediction in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: a real-world cohort study},
  journal = {Italian Journal of Medicine},
  year = {2026},
  volume = {20},
  number = {s1},
  doi = {10.4081/itjm.2026.2579}
}
Kostenlos starten →